# A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women

> **NCT07305779** · PHASE1 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** SEP-380135
- **DRUG:** Quinidine Gluconate

## Key facts

- **NCT ID:** NCT07305779
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-07
- **Primary completion:** 2025-05-03
- **Final completion:** 2025-05-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07305779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07305779, "A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07305779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*